SWKS
37
6
CME
59
4
NRG
45
3
SWK
46
-3
CMG
41
3
EMC
30
-6
AMZN
42
-2
KIM
50
13
LB
55
7
PCAR
56
11
ICE
63
6
BLK
49
3
VFC
59
-2
BMY
66
-3
FE
62
2
LRCX
56
-5
L
67
3
PGR
40
3
EFX
30
3
WM
80
6
SWKS
37
6
CME
59
4
NRG
45
3
SWK
46
-3
CMG
41
3
EMC
30
-6
AMZN
42
-2
KIM
50
13
LB
55
7
PCAR
56
11
ICE
63
6
BLK
49
3
VFC
59
-2
BMY
66
-3
FE
62
2
LRCX
56
-5
L
67
3
PGR
40
3
EFX
30
3
WM
80
6
Financhill
Back

MFS Intermediate High Income Fund Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Buy
59

CIF
MFS Intermediate High Income Fund

Last Price:
$1.63
Seasonality Move:
1.29%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Buy
59
MFS Intermediate High Income Fund (CIF) is a Buy

Is MFS Intermediate High Income Fund a Buy, Sell or Hold?

  • The current MFS Intermediate High Income Fund [CIF] share price is $1.63. The Score for CIF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • CIF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIF Stock Price Chart

What is MFS Intermediate High Income Fund's stock price today?

  • The MFS Intermediate High Income Fund share price today is $1.63
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CIF is experiencing slight buying pressure.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

CIF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.36 Buy
Relative Strength Index (14 RSI): 46.87 Sell
Chaikin Money Flow: 14950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.61 - 1.67) Sell
Bollinger Bands (100): (1.66 - 1.74) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

CIF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.61 Buy
20-day SMA: 1.63 Sell
50-day SMA: 1.67 Sell
200-day SMA: 1.72 Sell
8-day EMA: 1.59 Buy
20-day EMA: 1.29 Buy
50-day EMA: 0.77 Buy
200-day EMA: 0.24 Buy

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

MFS Intermediate High Income Fund Earnings Growth & CIF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

MFS Intermediate High Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):